| NCT ID | NCT05616312 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospitals Cleveland Medical Center |
| Condition | Education After Trauma |
| Study Type | INTERVENTIONAL |
| Enrollment | 216 participants |
| Start Date | 2022-10-13 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 216 participants in total. It began in 2022-10-13 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate whether receiving education after trauma surgeries affects three things: 1) knowledge about injury and treatment ("recall"), 2) how well patients follow treatment recommendations, and 3) how satisfied patients are with their care. To do so, some participants in this study will receive education, and some will not.
Eligibility Criteria
Inclusion Criteria: * Isolated open or closed fracture of the pelvis and/or lower extremity treated surgically Exclusion Criteria: * Patient receiving orthopedic care or follow-up at another institution * Non-English speaking * Incarcerated (or likely impending incarceration) * Currently enrolled in a study that does not permit co-enrollment * Traumatic brain injury, dementia, or other cognitive impairment
Contact & Investigator
John Sontich, MD
PRINCIPAL INVESTIGATOR
University Hospitals Cleveland Medical Center
Frequently Asked Questions
Who can join the NCT05616312 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Education After Trauma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05616312 currently recruiting?
Yes, NCT05616312 is actively recruiting participants. Contact the research team at kallie.chen@uhhospitals.org for enrollment information.
Where is the NCT05616312 trial being conducted?
This trial is being conducted at Cleveland, United States.
Who is sponsoring the NCT05616312 clinical trial?
NCT05616312 is sponsored by University Hospitals Cleveland Medical Center. The principal investigator is John Sontich, MD at University Hospitals Cleveland Medical Center. The trial plans to enroll 216 participants.